JimJimJimJim Posted June 23, 2013 Share Posted June 23, 2013 Jim Marshall (not a doctor) said ... Role of insulin in prostate cancer progression confirmed again. If you are diabetic, or headed that way, keep your blood sugar levels in control - diet, exercise and, if necessary, medication. Men who were metastatic, but still responding to hormone therapy (ADT) had their blood collected for an earlier trial. These researchers looked at that blood, and at how long the men took for their cancer to progress, and how long they survived. Insulin resistance was found to lead to earlier progression and earlier death. Higher insulin resistance is closely tied to abnormal blood sugar levels and type 2 diabetes. ... end Jim This abstract is only available for 24 hours for members to get an email. After 24 hours the abstract will only be available through the link to the ASCO site below. Serum insulin to predict time to castration-resistant progression and overall survival in metastatic androgen-dependent prostate cancer (mADPCa). Our data suggest that insulin levels are a biomarker for sensitivity to ADT and highlight the complex interactions between metabolism and PCa progression. CautionThis extract was published in association with the American Society of Clinical Oncology 2013 annual conference. Though the research behind it may have been excellent, your doctor cannot yet give much weight to it for a number of reasons, including: It is only an extract. The full paper may reveal information important for your treatment. The study has not yet had peer review - with doctors and researchers scrutinising the study closely for mistakes and limitations after it is published in a professional journal. Your doctor may already be aware of a limitations of the findings because of their wider reading. The link below is to a page or document that we do not control.Parts of it may be wrong or misleading.Check with your doctor if something interests you.If it is temporarily or permanently unavailable, you may receive an error message. Source URL: http://meetinglibrary.asco.org/content/117258-132 Link to comment Share on other sites More sharing options...
This topic is now archived and is closed to further replies.